Home › Hypopharyngeal Cancer › Kansas › Overland Park
Hypopharyngeal Cancer clinical trials in Overland Park, KS
4 studies for Hypopharyngeal Cancer are looking for participants at sites in and around Overland Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RecruitingPhase 1
- University of Kansas Clinical Research Center, Fairway · 3 mi away
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RecruitingPhase 3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Saint Luke's Cancer Instititute - South, Overland Park
Hypopharyngeal Cancer trials in other cities
- Atlanta, GA6 studies
- Chicago, IL6 studies
- Kansas City, MO5 studies
- Richmond, VA5 studies
- Cape Girardeau, MO5 studies
- Milwaukee, WI5 studies
- Joliet, IL5 studies
- Stevens Point, WI5 studies
- Wausau, WI5 studies
- Peoria, IL5 studies
- Bloomington, IL5 studies
- Kansas City, KS4 studies
Other studies in Overland Park
- Non-Small Cell Lung Cancer16 studies
- Acute Myeloid Leukemia11 studies
- Lung Cancer11 studies
- Breast Cancer10 studies
- Atrial Fibrillation8 studies
- Colorectal Cancer8 studies
- Obesity7 studies
- Pancreatic Cancer7 studies
- Prostate Cancer7 studies
- Melanoma6 studies
- Overweight6 studies
- Ovarian Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.